Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 158

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal

Open access
Loyse, A., Dromer, F., Day, J., Lortholary, O., Harrison, T. S.·2013·Journal of Antimicrobial Chemotherapy

Abstract

Current, widely accepted guidelines for the management of HIV-associated cryptococcal meningoencephalitis (CM) recommend amphotericin B combined with flucytosine (5-FC) for ≥2 weeks as the initial induction treatment of choice. However, access to flucytosine in Africa and Asia, where disease burden is greatest, is inadequate at present. While research into identifying effective and well-tolerated antifungal combinations that do not contain flucytosine continues, an ever-increasing body of evidence from in vitro, in vivo and clinical studies points to the benefits of flucytosine in the treatment of CM in both intravenous combinations with amphotericin B and oral combinations with high-dose fluconazole. This article provides an up-to-date review of this evidence, and the current issues and challenges regarding increasing access to this key component of combination antifungal therapy for cryptococcosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/jac/dkt221

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 158

Metadata

Authors
Loyse, A., Dromer, F., Day, J., Lortholary, O., & Harrison, T. S.
Venue
Journal of Antimicrobial Chemotherapy
Published
2013-06-20
Volume
68
Issue
11
Pages
2435-2444
ISSN
  • 0305-7453 (ISSN-L)
  • 1460-2091
OpenAlex
W2133750516
Cited by
158
References
8
FWCI
7.35
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal. https://app.cochat.ai/papers/10.1093/jac/dkt221
The paper
Loyse, A., Dromer, F., Day, J., Lortholary, O., & Harrison, T. S. (2013). Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkt221

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.